Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03910569 · ClinicalTrials.gov registry record
The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study
A clinical trial of Takotsubo Cardiomyopathy, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03910569: Recruiting study of Takotsubo Cardiomyopathy, sponsored by Cedars-Sinai Medical Center.
NCT03910569 is a study of Takotsubo Cardiomyopathy that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 1,000 participants, above the 197-participant average among 3 other Takotsubo Cardiomyopathy trials with a reported enrollment target (408% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03910569, a study of Takotsubo Cardiomyopathy, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Cedars-Sinai SHI Takotsubo Registry and Proteomic Study is an observational registry that will collect retrospective and prospective demographic, clinical, hemodynamic, laboratory and other diagnostic parameters, therapy and outcome data from individuals who meet the inclusion/exclusion criteria of Takotsubo Registry protocol. Subjects will also be invited to provide a blood sample utilizing a Mitra kit sent to their homes. Researchers from the Barbra Streisand Women's Heart Center will analyze Registry data to identify Takotsubo phenotypes, improve diagnostic capabilities, better predict recurrence rates, and develop targeted Takotsubo treatments.
Primary Outcome
Prevalence of the Takotsubo will be measured annually. Change from baseline will be assessed.
Conditions Studied
Study Locations (1)
California
- Cedars Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2029-02 |
What NCT03910569 shows while recruiting
NCT03910569 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 197-participant average among 3 other Takotsubo Cardiomyopathy trials with a reported enrollment target (408% higher).
The record links to 1 condition, with Takotsubo Cardiomyopathy appearing as the primary indexed condition, and to 0 interventions.
NCT03910569 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03910569 about?
NCT03910569 is a clinical study titled "The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study". The Cedars-Sinai SHI Takotsubo Registry and Proteomic Study is an observational registry that will collect retrospective and prospective demographic, clinical, hemodynamic, laboratory and other diagnostic parameters, therapy and outcome data from individuals who meet the inclusion/exclusion criteria...
What is the current status of trial NCT03910569?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2019-02-01. Estimated completion is 2029-02.
What conditions does trial NCT03910569 study?
This clinical trial studies the following conditions: Takotsubo Cardiomyopathy.
Who is sponsoring clinical trial NCT03910569?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03910569 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Takotsubo Cardiomyopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI